[JANX] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 14.96%
YoY- -30.45%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 2,517 1,813 1,159 0 -
PBT -11,568 -16,696 -10,766 -1,256 109.61%
Tax -500 -2,652 137 0 -
NP -11,568 -14,044 -10,766 -1,256 109.61%
Tax Rate - - - - -
Total Cost 14,085 15,857 11,925 1,256 123.83%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin -459.59 -774.63 -928.90 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.25 -0.34 -0.26 -0.10 35.72%
EPS Diluted -0.25 -0.34 -0.26 -0.10 35.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.